| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.688 | 30.715 | 31.104 | 25.232 | 2.529 | 2.481 | 2.426 | 2.433 | 2.426 | 2.412 |
| Total Income - EUR | 33.746 | 30.715 | 31.104 | 25.234 | 2.529 | 2.481 | 2.454 | 2.433 | 2.426 | 2.412 |
| Total Expenses - EUR | 35.748 | 36.392 | 34.996 | 31.326 | 2.346 | 2.103 | 1.684 | 2.251 | 1.417 | 829 |
| Gross Profit/Loss - EUR | -2.002 | -5.677 | -3.892 | -6.092 | 183 | 378 | 770 | 182 | 1.009 | 1.584 |
| Net Profit/Loss - EUR | -3.015 | -5.984 | -4.203 | -6.358 | 107 | 303 | 696 | 109 | 772 | 1.330 |
| Employees | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Die Krebs Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.874 | 16.262 | 15.555 | 14.846 | 14.142 | 13.466 | 12.769 | 12.408 | 11.972 | 11.508 |
| Current Assets | 2.991 | 1.618 | 1.604 | 142 | 216 | 248 | 1.578 | 43 | 336 | 2.045 |
| Inventories | 2.819 | 1.533 | 1.494 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 68 | 74 | 109 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Cash | 103 | 11 | 1 | 99 | 174 | 206 | 1.538 | 3 | 295 | 2.005 |
| Shareholders Funds | -3.747 | -9.693 | -13.732 | -19.171 | -18.692 | -17.993 | -16.898 | -16.841 | -16.019 | -14.599 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 29.232 | 33.136 | 36.360 | 39.527 | 37.012 | 34.529 | 33.235 | 29.769 | 28.326 | 28.152 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Die Krebs Srl